Supplementary Figure S10 from IL1RAP Antibody–Drug Conjugates Potently Target Primary and Metastatic Diseases in Multiple Oncofusion-Driven Cancers
Year: 2026
Type: supplementary-materials
Abstract: Supplementary Figure S10. Targeting IL1RAP by topoisomerase inhibitor-conjugated ADCs is highly efficacious and well-tolerated in multiple EwS CDX and PDX models.
Authors: Hai-Feng Zhang, Edouard De Dreuzy, Yue Zhou Huang, Seungmin Shin, Qing-Feng Huang, Alberto Delaidelli, Xiaqiu Yang, Virginia Adamiak, Andrew Lytle, Aarzoo Arzoo, Michael M. Lizardo, Qiaochu Lin, Shreya Sanadi, Melanie Rouleau, Lu-Xin Liu, Li-Yan Xu, En-Min Li, Raymond Lai, Clémentine Primus, Soha Reda El Sayed, Lucas Bourhis, Delphine Genin, Lucas Demontrond, Lucie Bouquet, Laura Labarthe Démolis, Amandine Barberot, Stephane Lameynardie, Alexis Delabrière, Haiqing Hua, Junjie Yang, Rieko Ishima, Roland Imle, Ana Banito, Graham W. Slack, Kerry J. Savage, John M. Maris, Kristopher R. Bosse, Dimiter S. Dimitrov, Christian Steidl, Wei Li, Richard C.A. Sainson, Poul H. Sorensen
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: gold
OpenAlex ID: W7204936794